Lantern Pharma (LTRN)

• Market cap: $33.9M
• 1 day: -1.87%
• 5 days: -6.25%
• 1 month: 7.14%
• 3 months: -21.05%
• 6 months: -29.05%
• Year to date: -24.46%
• 1 year: -18.81%
• 5 years: -78.93%
• 10 years: -78.93%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Employees: 21

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

773% more call options, than puts

Call options by funds: $192K | Put options by funds: $22K

0.45% more ownership

Funds ownership: 11.96% [Q2] → 12.4% (+0.45%) [Q3]

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

18% less capital invested

Capital invested by funds: $6.01M [Q2] → $4.9M (-$1.11M) [Q3]

21% less funds holding

Funds holding: 39 [Q2] → 31 (-8) [Q3]

67% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 12